Home / Market News / $DWTX

$DWTX news and market catalysts

The 4 most recent market catalysts affecting $DWTX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 1 high impact 2 bullish 1 bearish Biotechnology
Nov 5, 2026 Corporate Catalyst Neutral Impact 60
Dogwood Therapeutics Announces Third Quarter 2026 Financial Results
Dogwood Therapeutics filed an 8-K to announce its third-quarter 2026 financial results and provide a business update. This is a standard quarterly reporting event for publicly trad…
Oct 19, 2026 Corporate Catalyst Bullish Impact 65
Dogwood Therapeutics Enters Into Securities Subscription Agreement For $5 Investment From CK Life Sciences’ Subsidiary
Dogwood Therapeutics (DWTX) announced a $5 million investment from its largest shareholder, a subsidiary of CK Life Sciences, via a private placement of common stock at $1.22 per s…
Aug 13, 2026 Corporate Catalyst Bearish Impact 95
Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate
Dogwood Therapeutics reported Q2 EPS of $(0.34), missing analyst estimates of $(0.14) by a substantial 142.86%. This significant earnings miss indicates that the company's financia…
Jul 20, 2026 Corporate Catalyst Bullish Impact 65
Dogwood Therapeutics Admits First 200 Participants In Its Current HAL-CINP Phase 2b Study To Evaluate Efficacy, Safety Of Halneuron
Dogwood Therapeutics (DWTX) announced a significant operational milestone by successfully enrolling the first 200 patients in its HAL-CINP Phase 2b trial. This indicates progress i…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.